Erik Emerson

He assumed the role of CEO in September 2023. His experience extends from building commercial organizations to extensive fundraising and M&A transactions.

Before joining Apimeds, Mr. Emerson served as Chief Commercial Officer at Odyssey Health, Inc., where he was instrumental in driving commercial strategies. He also held the position of Chief Commercial Officer at Mezzion Pharmaceuticals, Inc., contributing to the company's growth and market presence.

In 2013, Mr. Emerson co-founded Symplmed Pharmaceuticals LLC and served as its President and Chief Executive Officer, leading the development and commercialization of pharmaceutical products. His earlier career includes roles as Senior Director of Commercial Development at XOMA Corporation and Marketing Director at Gilead Sciences, Inc., where he gained extensive experience in product development and marketing within the pharmaceutical industry.

Mr. Emerson holds an undergraduate degree from the University of Oregon. Erik is the father of 4 and enjoys golf, family, and the beach during his free time.